期刊信息查詢系統

期刊標題檢索 HERED CANCER CL 最新評論: Review Speed: 6.0 | Submission Hit Rate: 75.0 Experience Sharing: ... (2024-03-22)

讓學術交流變得簡單

發布您的作品並從國際研究社群獲取反饋

APA 與 LetPub 合作，為作者提供全方位服務

[Hereditary Cancer in Clinical Practice]您好，您是該頁面的第 11167 位訪客。

期刊簡介

期刊名稱

Hereditary Cancer in Clinical Practice
LetPub Score

4.9

50 ratings

Rate

Reputation

5.8

Influence

3.7

Speed

7.0

期刊簡稱

HERED CANCER CLIN PR

ISSN

1731-2302

E-ISSN

1897-4287

h-index

CiteScore

SJR

SNIP

CiteScore Rank

3.10

0.729

0.569

Subject field	Quartiles	Rank	Percentile
Category: Medicine Subcategory: Oncology	Q3	245 / 404
Category: Medicine Subcategory: Genetics (clinical)	Q3	68 / 99

自引率 (2023-2024)

5.00%自引率趨勢

掲載範囲

Hereditary Cancer in Clinical Practice is an open access journal that publishes articles of interest for the cancer genetics community and serves as a discussion forum for the development appropriate healthcare strategies.

Cancer genetics encompasses a wide variety of disciplines and knowledge in the field is rapidly growing, especially as the amount of information linking genetic differences to inherited cancer predispositions continues expanding. With the increased knowledge of genetic variability and how this relates to cancer risk there is a growing demand not only to disseminate this information into clinical practice but also to enable competent debate concerning how such information is managed and what it implies for patient care.

Topics covered by the journal include but are not limited to:

Original research articles on any aspect of inherited predispositions to cancer.
Reviews of inherited cancer predispositions.
Application of molecular and cytogenetic analysis to clinical decision making.
Clinical aspects of the management of hereditary cancers.
Genetic counselling issues associated with cancer genetics.
The role of registries in improving health care of patients with an inherited predisposition to cancer.

官方網站

http://hccpjournal.biomedcentral.com

在線稿件提交

https://www.editorialmanager.com/hccp

開放訪問

Yes

出版商

BioMed Central

主題領域

医学

出版國/地區

POLAND

發行頻率

四半期刊行

創刊年

2003

每年文章數

24每年文章數趨勢

黃金OA百分比

100.00%

OA Related Info

APC: Yes（ GBP1890; USD2590; EUR2190; ）
APC waiver：Check Notes
Other charges: No
Keywords: cancer genetics
Useful LinksAims & Scope Author Instructions Editorial Board Open peer review

Web of Science 四分位
（ 2023-2024）

WOS Quartile: Q3

Category	Edition	JIF Quartile	JIF Ranking	JIF Percentage
ONCOLOGY	SCIE	Q3	221/322

索引 (SCI or SCIE)

Science Citation Index Expanded

鏈接到PubMed Central (PMC)

https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1731-2302%5BISSN%5D

平均審稿時間 *

來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions

競爭力 *

來自作者的數據: Moderate

參考鏈接

相關期刊	【Hereditary Cancer in Clinical Practice】CiteScore趨勢
自引率趨勢	每年文章數趨勢
作者評論

*所有的審稿過程指標，如接受率和審稿速度，僅限於用戶提交的稿件。因此，這些指標可能無法準確反映期刊的競爭力或速度。

同一學科的期刊
CiteScore趨勢
自引率趨勢
每年文章數趨勢

學科內的可信期刊	影響因子
CA-A CANCER JOURNAL FOR CLINICIANS	H-index: 144 CiteScore: 873.20
Nature Reviews Clinical Oncology	H-index: 127 CiteScore: 99.40
NATURE REVIEWS CANCER	H-index: 396 CiteScore: 111.90
ANNALS OF ONCOLOGY	H-index: 210 CiteScore: 63.90
CANCER CELL	H-index: 295 CiteScore: 55.20
JOURNAL OF CLINICAL ONCOLOGY	H-index: 494 CiteScore: 41.20
LANCET ONCOLOGY	H-index: 274 CiteScore: 62.10
CANCER RESEARCH	H-index: 411 CiteScore: 16.10
SEMINARS IN CANCER BIOLOGY	H-index: 134 CiteScore: 26.80
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH	H-index: 67 CiteScore: 18.20

學科內最受檢索的期刊	頁面查看次數
CANCER LETTERS	330965
CANCER RESEARCH	312133
BMC CANCER	245502
Asian Pacific Journal of Cancer Prevention	219199
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH	198015
INTERNATIONAL JOURNAL OF CANCER	191629
CLINICAL CANCER RESEARCH	181666
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY	176409
ONCOLOGY REPORTS	175031
CA-A CANCER JOURNAL FOR CLINICIANS	163632

明年預測:
穩步上升無變化逐步下降　刷新

首頁上一頁 1 下一頁末頁 (頁 /1)
[Hereditary Cancer in Clinical Practice] 的評論	撰寫評論

作者: 文雯公子領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2024-03-22 20:34:05 評論於 Review Speed: 6.0 \| Submission Hit Rate: 75.0 Experience Sharing: The review process is fast, the editors are very tolerant, and there were hardly any questions asked. Publishing and rights complete: 16 Feb 2024 Submission is in publishing and rights: 15 Feb 2024 Peer review Submission status Date Submission accepted: 13 Feb 2024 Submission under peer review: 22 Jan 2024 Submission passed technical check: 22 Jan 2024 Revision received: 22 Jan 2024 Submission under peer review: 10 Oct 2023 Technical check Submission status Date Submission passed technical check: 10 Oct 2023 Amendment received: 06 Oct 2023 Submission is under technical check: 03 Oct 2023 Submission received Submission status Date Submission received: 03 Oct 2023 (0) 讚！ \| 文雯公子
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 23:42:52 評論於 Not all journals require this item to be filled out (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 23:01:20 評論於 RUNNING TITLE is shorter and typically printed in the header of published articles (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 破戒阳平領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-28 23:59:37 評論於 Is a running title necessary? (0) 讚！ \| 破戒阳平
作者: 八坂篷蔚領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-26 17:18:46 評論於 What is the difference between RUNNINGTITLE and TITLE? (0) 讚！ \| 八坂篷蔚
作者: Violet Bart 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2015-10-14 12:03:06 評論於 It's been 2 months, finally under review, how slow is the pace (0) 讚！ \| Violet Bart
作者: Violet Bart 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2015-09-10 23:48:41 評論於 There is no news yet, it's been almost a month, and the editor is still assigned (0) 讚！ \| Violet Bart

首頁上一頁 1 下一頁末頁 (頁 /1)

開始撰寫 [Hereditary Cancer in Clinical Practice] 的評論：

您的評論將是選擇期刊的重要參考信息。歡迎分享您的投稿經驗！
研究領域:
接受狀態:	審稿時間: 個月以內
您的評論:
姓名:	(建議: 請輸入有效的電子郵件地址以便與審稿者互動，或註冊LetPub帳戶。)
給管理員留言:	我的評論包含修正信息如果您發現該期刊頁面中有錯誤的信息或希望提供額外內容，請勾選此框。管理員將檢查並儘快更新期刊說明。
隨機碼:	點擊刷新

期刊名稱:	ISSN:	主題領域:	影響因子範圍: -
索引:	類別:	開放訪問:	排序方式:

作者: 文雯公子領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2024-03-22 20:34:05 評論於 Review Speed: 6.0 \| Submission Hit Rate: 75.0 Experience Sharing: The review process is fast, the editors are very tolerant, and there were hardly any questions asked. Publishing and rights complete: 16 Feb 2024 Submission is in publishing and rights: 15 Feb 2024 Peer review Submission status Date Submission accepted: 13 Feb 2024 Submission under peer review: 22 Jan 2024 Submission passed technical check: 22 Jan 2024 Revision received: 22 Jan 2024 Submission under peer review: 10 Oct 2023 Technical check Submission status Date Submission passed technical check: 10 Oct 2023 Amendment received: 06 Oct 2023 Submission is under technical check: 03 Oct 2023 Submission received Submission status Date Submission received: 03 Oct 2023 (0) 讚！ \| 文雯公子
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 23:42:52 評論於 Not all journals require this item to be filled out (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 维尔娜菲茨杰拉德領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-30 23:01:20 評論於 RUNNING TITLE is shorter and typically printed in the header of published articles (0) 讚！ \| 维尔娜菲茨杰拉德
作者: 破戒阳平領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-28 23:59:37 評論於 Is a running title necessary? (0) 讚！ \| 破戒阳平
作者: 八坂篷蔚領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2021-12-26 17:18:46 評論於 What is the difference between RUNNINGTITLE and TITLE? (0) 讚！ \| 八坂篷蔚
作者: Violet Bart 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2015-10-14 12:03:06 評論於 It's been 2 months, finally under review, how slow is the pace (0) 讚！ \| Violet Bart
作者: Violet Bart 領域: 医学審稿時間: 0.0 month(s) 結果: 待定＆不明撰寫評論	2015-09-10 23:48:41 評論於 There is no news yet, it's been almost a month, and the editor is still assigned (0) 讚！ \| Violet Bart

首頁上一頁 1 下一頁末頁 (頁 /1)

Hereditary Cancer in Clinical Practice

期刊標題檢索 HERED CANCER CL 最新評論: Review Speed: 6.0 | Submission Hit Rate: 75.0 Experience Sharing: ... (2024-03-22)

[Hereditary Cancer in Clinical Practice]您好，您是該頁面的第 11167 位訪客。

開始撰寫 [Hereditary Cancer in Clinical Practice] 的評論：

Contact us